Jacobs Levy Equity Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-49,100
| Closed | -$116K | – | 1187 |
|
|
2020
Q1 | $116K | Sell |
49,100
-155,600
| -76% | -$368K | ﹤0.01% | 951 |
|
|
2019
Q4 | $962K | Buy |
+204,700
| New | +$962K | 0.01% | 698 |
|
|
2019
Q2 | – | Sell |
-110,408
| Closed | -$335K | – | 1061 |
|
|
2019
Q1 | $335K | Sell |
110,408
-200,992
| -65% | -$610K | ﹤0.01% | 828 |
|
|
2018
Q4 | $847K | Buy |
+311,400
| New | +$847K | 0.01% | 635 |
|
|
2017
Q3 | – | Sell |
-28,970
| Closed | -$93K | – | 1034 |
|
|
2017
Q2 | $93K | Sell |
28,970
-109,542
| -79% | -$352K | ﹤0.01% | 897 |
|
|
2017
Q1 | $393K | Buy |
+138,512
| New | +$393K | 0.01% | 687 |
|
|
2016
Q2 | – | Sell |
-75,300
| Closed | -$66K | – | 1257 |
|
|
2016
Q1 | $66K | Buy |
+75,300
| New | +$66K | ﹤0.01% | 1056 |
|